[HTML][HTML] PRL3 as a therapeutic target for novel cancer immunotherapy in multiple cancer types

PL Chia, KH Ang, M Thura, Q Zeng - Theranostics, 2023 - ncbi.nlm.nih.gov
Abstract Phosphatase of Regenerating Liver-3 (PRL3) was discovered in 1998 and was
subsequently found to be correlated with cancer progression and metastasis in 2001 …

PRL1 and PRL3 promote macropinocytosis via its lipid phosphatase activity

Z Ye, CP Ng, H Liu, Q Bao, S Xu, D Zu, Y He… - …, 2024 - pmc.ncbi.nlm.nih.gov
PRL1 and PRL3, members of the protein tyrosine phosphatase family, have been
associated with cancer metastasis and poor prognosis. Despite extensive research on their …

[HTML][HTML] Auxiliary Diagnosis and Prognostic Value of Dehydrogenase/Reductase 2 (DHRS2) in Various Tumors

Z An, W Bo, J Qin, L Jiang, J Jiang - Iranian Journal of Public …, 2023 - ncbi.nlm.nih.gov
Background: As the most convenient and commonly used for clinical diagnosis, cancer
biomarker has been widely used in the auxiliary diagnosis of tumors, the observation of …